Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease

Blood

Volumn 113, Issue 18, 2009, Pages 4458-4467

  Pillai, Asha B ^a,b   George, Tracy I ^a   Dutt, Suparna ^a   Strober, Samuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; T LYMPHOCYTE ANTIBODY; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; IL2RA PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR ALPHA;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; COLON; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; LYMPH NODE IRRADIATION; LYMPHOID TISSUE; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY T LYMPHOCYTE; ADOPTIVE TRANSFER; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CYTOLOGY; DONOR; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; SPLEEN; TRANSPLANTATION; WHOLE BODY RADIATION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRAFT VS HOST DISEASE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; SPLEEN; T-LYMPHOCYTES, REGULATORY; TISSUE DONORS; WHOLE-BODY IRRADIATION;

EID: 66149101300     PISSN: 00064971     EISSN: 15280020     Source Type: None    
DOI: 10.1182/blood-2008-06-165506     Document Type: Article

References (50)

1. Ferrara JL. Hematopoietic Stem Cell Transplantation. Malden, MA; Blackwell Science; 1999.
2. Wysocki C, Jiang Q, Panoskalsis-Mortari A. Leukocyte migration and graft-versus-host disease. Blood. 2005;105:4191-4199.
3. 7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. Blood. 2005;106:4009-4015.
4. Kaplan DH, Anderson BE, McNiff JM, et al. Target antigens determine graft-versus-host disease phenotype. J Immunol. 2004;173:5467-5475.
5. Ferrara JL, Cooke KR, Teshima T. The pathophysiology of acute graft-versus-host disease. Int J Hematol. 2003;78:181-187.
6. + T cells reciprocally regulate acute graft versus host disease. J Exp Med. 1999;189:1073-1081.
7. Pillai AB, George TI, Dutt S, Teo P, Strober S. Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation. J Immunol. 2007;178: 6242-6251. (Pubitemid 46717407)
8. Hashimoto D, Asakura S, Miyake S, et al. Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells. J Immunol. 2005;174:551-556. (Pubitemid 40007446)
9. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196:389-399.
10. Edinger M, Hoffmann P, Ermann J, et al. CD4+CD25+ regulatory T cells preserve graft-versus- tumor activity while inhibiting graft-versus- host disease after bone marrow transplantation. Nat Med. 2003;9:1144-1150. (Pubitemid 37173698)
11. + T cells that survive irradiation regulate chronic graft-versus-host disease. Blood. 2004; 104:1565-1573.
12. + T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells. J Immunol. 2001;167:2087-2096.
13. Lan F, Zeng D, Higuchi M, Higgins JP, Strober S. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus- host disease: the role of CD1-reactive natural killer T cells. Biol Blood Marrow Transplant. 2003;9:355-363. (Pubitemid 38351806)
14. + regulatory T cells protects from lethal acute GVHD. Blood. 2005;105:2220-2226.
15. +CD25+ regulatory T cells during acute graftversus- host disease. Blood. 2005;106:3300-3307.
16. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol. 2003;167:1945-1953.
17. Kronenberg M. Toward an understanding of NKT-cell biology: progress and paradoxes. Annu Rev Immunol. 2005;23:877-900. (Pubitemid 40563188)
18. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu Rev Immunol. 2003;21:483-513. (Pubitemid 37174539)
19. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol. 2004;22: 817-890. (Pubitemid 38680443)
20. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today. 2000;21:573-583.
21. Van Kaer L, Joyce S. Innate immunity: NKT cells in the spotlight. Curr Biol. 2005;15:R429-R431. (Pubitemid 40772144)
22. Singh N, Hong S, Scherer DC, et al. Cutting edge: activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol. 1999;163:2373-2377. (Pubitemid 29399153)
23. + cells. Blood. 2003;101:2024-2032.
24. Field EH, Rouse TM. Alloantigen priming after total lymphoid irradiation alters alloimmune cytokine responses. Transplantation. 1995;60:695-702.
25. Fowler DH, Kurasawa K, Husebekk A, Cohen PA, Gress RE. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graftversus- host reaction: regulation of cytokines and CD8+ lymphoid engraftment. J Immunol. 1994; 152:1004-1013. (Pubitemid 24983776)
26. + donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol. 1995;155:585-593.
27. Minami K, Yanagawa Y, Iwabuchi K, et al. Negative feedback regulation of T helper type 1 (Th1)/ Th2 cytokine balance via dendritic cell and natural killer T cell interactions. Blood. 2005;106: 1685-1693. (Pubitemid 41208582)
28. Sakaguchi S. Regulatory T cells: Meden Agan. Immunol Rev. 2006;212:5-7.
29. Tang Q, Bluestone JA. Regulatory T cell physiology and application to treat autoimmunity. Immunol Rev. 2006;212:217-237. (Pubitemid 44116711)
30. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol. 2003;3:199-210.
31. + T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001;193:1285-1294.
32. Izcue A, Coombes J, Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev. 2006;212:256-271. (Pubitemid 44116713)
33. + regulatory T cells including suppressors of alloreactivity. Immunol Rev. 2006; 212:314-329.
34. + T cells with regulatory properties by repetitive stimulation with immature human dendritic cells. J Exp Med. 2000;192:1213-1222.
35. + T regulatory cells in the prevention of autoimmune myasthenia. J Immunol. 2005;175:1898-1904.
36. + regulatory T cells? Eur J Immunol. 2005;35:1193-1200.
37. Lowsky R, Takahashi T, Liu YP, et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med. 2005;353:1321-1331. (Pubitemid 41362700)
38. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and chimerism after renal and hematopoietic- cell transplantation. N Engl J Med. 2008;358:362-368. (Pubitemid 351159235)
39. Cui J, Shin T, Kawano T, et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science. 1997;278:1623-1626. (Pubitemid 27516281)
40. Fontenot J, Rasmussen J, Williams L, Dooley J, Rudensky A. Regulatory T cell lineage specification by the forkhead box transcription factor Foxp3. Immunity. 2005;22:329-341. (Pubitemid 40387475)
41. + precursors. J Immunol. 2005;175:6107-6116.
42. + regulatory T cells. Proc Natl Acad Sci U S A. 2007;104:18169-18174.
43. Mantel P, Kuipers H, Boyman O, et al. GATA3- driven Th2 responses inhibit TGF-β1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 2007;5:e329. (Pubitemid 351159712)
44. Takaki H, Ichiyama K, Koga K, et al. STAT6 inhibits TGF-β1-induced Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J Biol Chem. 2008;283:14955-14962.
45. - effector T cells. Nat Immunol. 2008;9:1347-1355.
46. + regulatory T cells requires a second signal mediated by Stat6. J Immunol. 2007;178:7550-7556.
47. + T regulatory cell-mediated suppression. J Immunol. 2005;174:7645-7653.
48. + regulatory T cell function. J Autoimmun. 2005;25:112-120.
49. + T cells are resistant to glucocorticoid- induced apoptosis: implications for the Th1/Th2 balance. J Immunol. 1998;161:1239-1247.
50. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med. 2001;193:1311-1318.